Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,118 across all filing types
Latest filing 2023-10-19 Transaction in Own Shar…
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is a detailed notification of a daily buy-back activity by Mayne Pharma Group Limited. It includes specifics such as the number of securities bought back, prices paid, broker details, dates, and regulatory compliance references (e.g., ASX listing rules). The content focuses exclusively on the company's share repurchase program and daily updates related to it. There is no indication of financial statements, earnings data, management commentary, or other report types. This matches the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buy-back or sale of its own shares.
2023-10-19 English
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is a detailed notification about a company's share buy-back activity, including daily updates on the number of shares bought back, prices paid, broker information, and regulatory compliance details. It specifically mentions 'Notification of buy-back' and 'Daily buy-back notification' multiple times, indicating it is an ongoing update about the company's repurchase of its own shares. This fits the category of a report on the company's transactions in its own shares rather than a financial report or announcement of a report. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and content confirm it is not a brief announcement but a substantive update on buy-back activity.
2023-10-18 English
Mayne Pharma provides update on 1Q FY24 trading and outlook 28 pages 1.0MB
Interim / Quarterly Report Classification · 95% confidence The document is a detailed update on Mayne Pharma's first quarter trading and outlook for FY24. It includes comprehensive financial performance data such as net sales, gross margin, EBITDA, segment contributions, cost structure, capital management, and outlook commentary. The document also mentions a webcast for investors and analysts and includes forward-looking statements. The length is substantial (15,000 characters), and it contains actual financial data and analysis for a quarterly period. This fits the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data and analysis. It is not merely an announcement or presentation, nor is it a full annual report or earnings release with only highlights. Therefore, the correct classification is IR with high confidence. Q1 2024
2023-10-17 English
Notification regarding unquoted securities - MYX 6 pages 28.0KB
Share Issue/Capital Change Classification · 100% confidence The document is a notification regarding the issue, conversion, or payment up of unquoted equity securities by Mayne Pharma Group Limited. It details the number and type of securities issued or converted, dates of conversion, and mentions securities issued under an employee incentive scheme. It also identifies key management personnel involved in the conversion. The content focuses on changes in the company's share capital structure, specifically the issuance and conversion of securities, rather than financial results, management changes, or regulatory compliance. This matches the definition of a Share Issue/Capital Change filing, which covers announcements about new share issues or capital structure changes.
2023-09-28 English
Notification regarding unquoted securities - MYX 7 pages 29.8KB
Share Issue/Capital Change Classification · 100% confidence The document is a notification regarding the issue of unquoted equity securities under an employee incentive scheme by Mayne Pharma Group Limited. It details the number and type of securities issued, dates, and compliance with ASX listing rules. There is no financial performance data, earnings information, or management discussion. The content focuses on the issuance of securities, which aligns with announcements about new share issues or capital changes. Therefore, the document fits the category of Share Issue/Capital Change (SHA). The document length and detail confirm it is the announcement itself, not a brief notice or a report publication announcement.
2023-09-28 English
Notification regarding unquoted securities - MYX 7 pages 29.6KB
Share Issue/Capital Change Classification · 100% confidence The document is a notification regarding the issue of unquoted equity securities under an employee incentive scheme by Mayne Pharma Group Limited. It details the number and type of securities issued, dates, and compliance with ASX listing rules. There is no financial performance data, earnings information, or management discussion. The content focuses on the issuance of securities, which aligns with announcements about share issues or capital changes. Therefore, the document fits the category of Share Issue/Capital Change (SHA). The document length and detail confirm it is not a brief announcement but a full notification of share issuance.
2023-09-28 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.